Journal for ImmunoTherapy of Cancer (Jun 2020)

Correction: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

  • Janice M Mehnert,
  • Isaac Brownell,
  • Sandra P D'Angelo,
  • Kent C Shih,
  • Karl D Lewis,
  • Gerald P Linette,
  • Sara Georges,
  • Parantu Shah,
  • Barbara Ellers-Lenz,
  • Gülseren Güzel,
  • Paul T Nghiem

DOI
https://doi.org/10.1136/jitc-2020-0796-5corr1
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

No abstracts available.